Randomized Comparison of Initiating the Fixed-Ratio Combination of iGlarLixi or Biosimilar Insulin Glargine Together With Gliclazide in South Asian Origin Participants With Type 2 Diabetes: VARIATION 2 SA Trial.
Can J Diabetes. 2022 Feb 11:S1499-2671(22)00015-6. doi: 10.1016/j.jcjd.2022.02.003. Online ahead of print.
Can J Diabetes. 2022.
PMID: 35752566